CAMBRIDGE, Mass.--(BUSINESS WIRE)--sphingotec GmbH (www.sphingotec.de/en/) announced today that it has established its U.S. headquarters in Cambridge, Massachusetts. The Germany-based biotechnology company develops tests to detect individual risk factors for cancer, cardiovascular conditions and kidney disease. Its expansion into the U.S. will enable sphingotec to more rapidly meet growing market demand.
Commercial activities in the U.S. will be led by Karla M. Gonye, who will serve as president of the U.S. subsidiary. Gonye’s experience includes more than 20 years in the biotech, pharmaceutical and diagnostic industries. Most recently, Gonye led worldwide marketing and market development activities for BG Medicine.
Hey, check out all the research scientist jobs. Post your resume today!
